Decline of cytology-based cervical cancer screening for COVID-19: a single-center Peruvian experience.
Víctor Rojas-ZumaranEder Walttuoni-PicónGerardo Campos-SicchaGloria Cruz-GonzalesLilian Huiza-EspinozaJeel Moya-SalazarPublished in: Medwave (2022)
Our results suggest a dramatic decrease in cervical cancer screening based on Papanicolaou smears during 2020 in Peru due to prevention and control measures against COVID-19.